Tuesday February 9 2010 | Biotechnology feed | All feeds

BioPortfolio Biotechnology Pharmaceutical Healthcare Medical Life Science Drug Discovery Disease

Image Results

Loading...
Loading...

TACLONEX Pages on BioPortfolio:

Biotechnology News TACLONEX Search
Biotechnology and Pharmaceutical Industry Search Find Companies, News, Events, Jobs, Directory.
http://www.bioportfolio.co.uk/TACLONEX-news.htm...

BioPortfolio - Taclonex
Taclonex - BioPortfolio - Indepth. ... Companies working in the area of Taclonex from Bioportfolio's Biocorporate database : BioPortfolio Logo. Company Name ...
http://www.bioportfolio.com/indepth/Taclonex.html...

BioPortfolio's Approved Drugs News by Tradename - T to Th
... News updated every 20 minutes from thousands of internet sites. Click the link below to view the latest news: TAB-PROFEN · TACARYL · TACE · TACLONEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_n...

BioPortfolio News: LEO Pharma - LEO Pharma Officially Launches in ...
19 Jan 2010 ... TACLONEX (calcipotriene 0.005% and betamethasone dipropionate ... For full prescribing information for TACLONEX(R), visit www.taclonex.com. ...
http://www.bioportfolio.com/news/LEO-Pharma-Officially-Launc...

BioPortfolio's Approved Drugs News by Tradename - T to Th
Approved Drug Profile Alphabetical listing by Tradename - "T to Th" Click the link below to view profiles: TAB-PROFEN · TACARYL · TACE · TACLONEX ...
http://www.bioportfolio.co.uk/approved_drugs/approved_drug_p...

BioPortfolio - Warner Chilcott
We strengthened and extended our position in the market for psoriasis therapies with the April 2006 launch of Taclonex® the first once-a-day topical ...
http://www.bioportfolio.com/biocorporate/10947-Warner+Chilco...

The Dermatology Market Outlook to 2013: Competitive landscape ...
... treatments is forecast to register strong growth between 2008-2013, driven by the performances of key drugs such as Raptiva, Taclonex, Soriatane. ...
http://www.bioportfolio.com/cgi-bin/acatalog/The-Dermatology...

BioPortfolio News: Warner Chilcott plc - Warner Chilcott Reports ...
Net sales of TACLONEX decreased $9.2 million, or 24.0%, to $29.0 million in the ... The decrease in TACLONEX net sales was primarily due to a contraction in ...
http://www.bioportfolio.com/news/Warner-Chilcott-Reports-Ope...

The World Dermatological Market Outlook 2010-2024
Taclonex • Dovonex • Propecia • Doryx • Surgicel Comprehensive analysis of the global dermatology market. The World Dermatological Market Outlook 2010-2024 ...
http://www.bioportfolio.com/cgi-bin/acatalog/The-World-Derma...

BioPortfolio Limited The World Dermatological Market Outlook 2010-2024
7.4.1 Sales Forecast for Taclonex, 2009-2024 7.5 Dovonex (Calcipotriol) .... Figure 7.7 Taclonex Sales Forecast ($m), 2009-2024 ...
http://www.bioportfolio.com/cgi-bin/acatalog/info_2230.html...

Results from other life science and pharmaceutical sites:

FDA Approvals: Climara Pro, Taclonex, Vivaglobin
The FDA has approved a new indication for an estradiol-levonorgestrel transdermal system, calcipotriene-betamethasone dipropionate 0.005%/0.064%
ointment, ...
http://www.medscape.com/viewarticle/521938...

DailyMed: About DailyMed
Taclonex Scalp® Topical Suspension is a vitamin D analog and .... Taclonex Scalp ® Topical Suspension contains calcipotriene that has been shown to be ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=14692...

FDA Approves Warner Chilcott's And LEO Pharma's Taclonex(R) - Once ...
LEO Pharma submitted the NDA for Taclonex® to the FDA in March 2005. Taclonex® is a topical ointment containing a combination of calcipotriene 0.005% and ...
http://www.biospace.com/news_story.aspx?NewsEntityId=6564...

TACLONEX (calcipotriene and betamethasone dipropionate) ointment ...
Each gram of Taclonex® Ointment contains 52.18 mcg of calcipotriene hydrate ( equivalent to 50 mcg of calcipotriene) and 0.643 mg of betamethasone ...
http://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?id=13853...

Taclonex (calcipotriene 0.005% and betamethasone dipropionate ...
Taclonex (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ointment. Abramovits W, Perlmutter A, Gupta AK. Baylor University Medical Center, ...
http://www.ncbi.nlm.nih.gov/pubmed/16687982...

Warner Chilcott And LEO Pharma Release: Taclonex(R) New Dual ...
3 Apr 2006 ... Warner Chilcott and LEO Pharma announced today that Taclonex® (calcipotriene 0.005% and betamethasone dipropionate 0.064%), a once-daily ...
http://www.biospace.com/news_story.aspx?NewsEntityId=14369...



...

Important Safety Information about Taclonex Scalpо Topical ...
Taclonex Scalpо is for the treatment of moderate to severe psoriasis ... You should not use Taclonex Scalpо if you have a history of allergy to any of its
...
http://www.wcrx.com/pdfs/TaclonexScalp.pdf...

Antipsoriatics - Pharmacy Clinical Policy Bulletins Aetna Medicare ...
Aetna considers Taclonex, Taclonex Scalp and Vectical to be medically ... Aetna considers Dovonex, Oxsoralen (lotion), Taclonex Scalp, Taclonex and Vectical ...
http://www.aetna.com/products/rxmedicare/data/Medicare2009/D...

Warner Chilcott
Taclonex® Ointment (calcipotriene 0.005% and betamethasone dipropionate 0.064%) ... Taclonex Scalp® Topical Suspension (calcipotriene 0.005% and ...
http://www.wcrx.com/products_dermatology.jsp...

Google Custom Search

Search
  


 

Nothing in this website should be used in place of personal medical advice from your own qualified medical practitioner.

All rights reserved. All other trademarks recognized.
Copyright 1997-2010 - BioPortfolio Limited.